Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: A qualitative and quantitative study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Mortensen, Gitte Lee ^a  

^a AnthroConsult ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; DENMARK; FEMALE; HUMAN; INFORMATION PROCESSING; INTERVIEW; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; STATISTICS; UTERINE CERVIX TUMOR;

ADOLESCENT; ADULT; DENMARK; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITATIVE RESEARCH; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77649216744     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-68     Document Type: Article

References (57)

1. The causal relation between human papillomavirus and cervical cancer. FX Bosch A Lorincz N Mũoz CJLM Meijer KV Shah, J Clin Pathol 2002 55 244 265 11919208 (Pubitemid 34293391)
2. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. J Ferlay F Bray P Pisani DM Parkin, IARC CancerBase No. 5, version 2.0 Lyon: IARCPress 2004
3. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. SK Kjaer TN Tran P Sparen, J Infect Dis 2007 196 1447 1454 10.1086/522863 18008222
4. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. DM Harper EL Franco CM Wheeler AB Moscicki B Romanowski CM Roteli-Martins D Jenkins A Schuind SA Costa Clemens G Dubin HPV Vaccine Study group, Lancet 2006 367 1247 1255 10.1016/S0140-6736(06)68439-0 16631880
5. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. N Mũoz R Manalastas Jr P Pitisuttithum D Tresukosol J Monsonego K Ault C Clavel J Luna E Myers S Hood O Bautista J Bryan FJ Taddeo MT Esser S Vuocolo RM Haupt E Barr A Saah, Lancet 2009 373 1949 1957 10.1016/S0140-6736(09)60691-7 19493565
6. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. LL Villa RL Costa CA Petta RP Andrade KA Ault AR Giuliano CM Wheeler LA Koutsky C Malm M Lehtinen FE Skjeldestad SE Olsson M Steinwall DR Brown RJ Kurman BM Ronnett MH Stoler A Ferenczy DM Harper GM Tamms J Yu L Lupinacci R Railkar FJ Taddeo KU Jansen MT Esser HL Sings AJ Saah E Barr, Lancet Oncol 2005 6 271 278 10.1016/S1470- 2045(05)70101-7 15863374
7. A scientific response to prevent cervical cancer in the world. FX Bosch Editors M Stanley TC Wright EL Franco R Herrero N Mũoz J Cuzick SM Garland, Vaccine 2008 26 Suppl 10 &22 vi 18847563
8. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. CJN Lacey CM Lowndes KV Shah, Vaccine 2006 24 Suppl 3 35 41 10.1016/j.vaccine.2006.06.015 (Pubitemid 44293033)
9. World Health Organization/Institut Catal d'Oncologia (WHO/ICO) Information Centre on HPV and Cervical Cancer. http://www.who.int/hpvcentre/ publications/en/
10. Danish Centre for Health Technology Assessment, Reduction in the Risk of Cervical Cancer by Vaccination against Human Papillomavirus (HPV) - a Health Technology Assessment Copenhagen: National Board of Health 2007
11. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. L Brabin SA Roberts F Farzaneh HC Kitchener, Vaccine 2006 24 3087 3094 10.1016/j.vaccine.2006.01.048 16500736
12. Viral sexually transmitted disease vaccine acceptability among college students. CW Boehner SR Howe DI Bernstein SL Rosenthal, Sex Transm Dis 2003 30 774 778 10.1097/01.OLQ.0000078823.05041.9E 14520177
13. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. K Davis ED Dickman D Ferris JK Dias, J Low Genit Tract Dis 2004 8 188 194 10.1097/00128360-200407000-00005 15874862
14. Attitudes about human papillomavirus vaccine in young women. JA Kahn SL Rosenthal T Hamann DI Bernstein, Int J STD AIDS 2003 14 300 306 10.1258/095646203321605486 12803935
15. Are women ready for the HPV vaccine? BM Slomovitz CC Sun M Frumovitz PT Soliman KM Schmeler HC Pearson A Berenson PT Ramirez KH Lu DC Bodurka, Gynecol Oncol 2006 103 151 154 10.1016/j.ygyno.2006.02.003 16551476
16. Parental attitudes to pre-pubertal HPV vaccination. LA Marlow J Waller J Wardle, Vaccine 2007 25 1945 1952 10.1016/j.vaccine.2007.01.059 17284337
17. Predictors of human papillomavirus vaccination acceptability among underserved women. MA Gerend SC Lee JE Shepherd, Sex Transm Dis 2007 34 468 471 17139233
18. Acceptability of human papillomavirus immunization. GD Zimet RM Mays Y Winston R Kee J Dickes L Su, J Womens Health Gend Based Med 2000 9 47 50 10.1089/152460900318957 10718505
19. Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. J Waller LA Marlow J Wardle, Cancer Epidemiol Biomarkers Prev 2006 15 1257 1261 10.1158/1055-9965.EPI-06-0041 16835320
20. Parental response to the introduction of a vaccine against human papilloma virus. K Noakes J Yarwood D Salisbury, Hum Vaccin 2006 2 243 248 17102643
21. Parental perspectives on vaccinating children against sexually transmitted infections. RM Mays LA Sturm GD Zimet, Soc Sci Med 2004 58 1405 1413 10.1016/S0277-9536(03)00335-6 14759685
22. Parental acceptance of the human papillomavirus vaccine. E Olshen ER Woods SB Austin M Luskin H Bauchner, J Adolesc Health 2005 37 248 251 10.1016/j.jadohealth.2005.05.016 16109349
23. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. AL Friedman H Shepheard, Health Educ Behav 2007 34 471 485 10.1177/1090198106292022 17000622
24. Knowledge and acceptance of human papillomavirus vaccination: perspectives of young Australians living in Melbourne, Australia. A McClelland P Liamputtong, Sex Health 2006 3 95 101 10.1071/SH05035 16800395
25. Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. DR Hoover B Carfioli EA Moench, Health Care Women Int 2000 21 375 391 10.1080/07399330050082227 11261108
26. Efficacy of the theory of planned behaviour: a meta-analytical review. CM Armitage M Connor, Br J Soc Psychol 2001 40 417 499 10.1348/014466601164939 11593942
27. FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus. Rapid Approval Marks Major Advancement in Public Health. FDA News Release, 2006 http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/2006/ucm108666.htm
28. Fokus på kræft (Focus on Cancer). Stor tilslutning til HPV vaccine (Massive uptake of HPV vaccination); No. 1, April. The National Board of Health News Centre, 2009 http://www.sst.dk/Nyhedscenter/Nyhedsbreve/ Nyt%20om%20kraeft/Nr%201%20April%202009.aspx?item={CC3D9876-CC03-4111-AFC0- 0023FFD78EF4
29. Sociological methods: A Sourcebook. NK Denzin ed, New Brunswick, New Jersey: Transaction Publishers 5 2006 17015731
30. K Malterud, Kvalitative Metoder i Medicinsk Forskning (Qualitative Methods in Medical Research) Oslo: University Press 2004
31. P Bourdieu, Outline of a Theory of Practice Cambridge: Cambridge University Press 1977
32. B Halkier, Fokusgrupper (Focus Groups) Roskilde: Roskilde University Press 2003
33. P Berger T Luckmann, The Social Construction of Reality Harmondsworth: Penguin Books 1987
34. M Gullestad, Kultur og Hverdagsliv (Culture and Everyday Life) Oslo: University Press 1989
35. M Bloor J Frankland M Thomas K Robson, Focus Groups in Qualitative Research London: Sage 2001
36. DL Morgan, Focus Groups as Qualitative Research London: Sage 1997
37. M Winther Jørgensen L Phillips, Diskursanalyse som Teori og Metode (Discourse Analysis as Theory and Method) Roskilde: Roskilde University Press 1999
38. JP Spradley, The ethnographic interview New York: Holt, Rinehart and Winston 1979
39. Human papillomavirus vaccine: knowledge and attitudes in two Appalachian Kentucky counties. C Hopenhayn A Christian W Jay Christian NE Schoenberg, Cancer Causes Control 2007 18 627 634 10.1007/s10552-007-9007-7 17497223
40. Trust and experience as predictors of HPV vaccine acceptance. LAV Marlow J Waller J Wardle, Human Vaccines 2007 3 171 175 17622801
41. Acceptance of human papillomavirus vaccination among californian parents of daughters: a representative statewide analysis. NA Constantine P Jerman, J Adolesc Health 2007 40 108 115 10.1016/j.jadohealth.2006.10.007 17259050
42. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. G Di Giuseppe R Abbate G Liguori L Albano IF Angelillo, Br J Cancer 2008 99 225 229 10.1038/sj.bjc.6604454 18628763
43. A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. H Marshall P Ryan D Roberton, Aust N Z J Public Health 2007 31 235 242 10.1111/j.1467-842X.2007.00054.x 17679241
44. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. C Sauvageau B Duval V Gilca F Lavoie M Ouakki, BMC Public Health 2007 7 304 10.1186/1471-2458-7-304 17961209
45. Women's knowledge, attitudes, and intentions concerning human papillomavirus vaccination: findings of a waiting room survey of obstetrics-gynaecology outpatients. JG Lenehan KC Leonard S Nandra CR Isaacs A Mathew WA Fisher, J Obstet Gynaecol Can 2008 30 489 499 18611300
46. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. M Jones R Cook, J Am Coll Health 2008 57 23 32 10.3200/JACH.57.1.23-32 18682342
47. Correlates of intent to be vaccinated against human papillomavirus: a exploratory study of college-aged women. R Crosby N Schoenberg C Hopenhayn G Moore W Melhan, Sex Health 2007 4 71 73 10.1071/SH06046 17382042
48. Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women. NR Sperber NT Brewer JS Smith, Cancer Causes Control 2008 19 115 118 10.1007/s10552-007-9074-9 17952620
49. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. NT Brewer KI Fazekas, Prev Med 2007 45 107 114 10.1016/j.ypmed.2007.05. 013 17628649
50. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. SL Rosenthal R Rupp GD Zimet HM Meza ML Loza MB Short PA Succop, J Adolesc Health 2008 43 239 245 10.1016/j.jadohealth.2008.06. 009 18710678
51. Parental intention to have daughters receive the human papillomavirus vaccine. GS Ogilvie VP Remple F Marra SA McNeil M Naus KL Pielak TG Ehlen SR Dobson DM Money DM Patrick, CMAJ 2007 177 1506 1512 18056599
52. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. JA Kahn SL Rosenthal Y Jin B Huang A Namakydoust GD Zimet, Obstet Gynecol 2008 111 1103 10 18448742
53. Parental attitudes and information needs in an adolescent HPV vaccination programme. R Stretch SA Roberts R McCann D Baxter G Chambers H Kitchener L Brabin, Br J Cancer 2008 99 1908 1911 10.1038/sj.bjc.6604766 18985038
54. Kvinders erfaringer med celleforandringer (Women's experiences with cell changes. GL Mortensen AL Adeler, Ugeskr Læger 2009 171 1934 1938
55. Kondylompatienters livskvalitet (Quality of life of patients with condyloma. GL Mortensen HK Larsen, Ugeskr Læger 2008 170 3858 3862
56. Livskvalitet hos homoseksuelle mænd med kondylomer (The quality of life of male homosexual patients with condyloma. GL Mortensen HK Larsen, Ugeskr Læger 2009 171 2561 2565
57. Kendskab til humant papillomvirus-relateret sygdom blandt kvinder i almen praksis (Knowledge of human papilloma virus-associated disease among women in general practice. LK Petersen J Nielsen H Væsel PH Brønsgaard P Kolby KG Madsen, Ugeskr Læger 2009 171 1173 1177